Keywords included macular degeneration with preference or utility or names of all possible techniques/tools used to derive utility or other synonyms. Original articles reporting health state utilities of patients with AMD were included. All articles were reviewed and extracted independently by two investigators for study design, population and outcomes. Meta-analyses were performed using DerSimonian and Laird method under a random-effects model. RESULTS: Out of 1887 studies identifi ed, 24 studies met inclusion criteria. Twenty-one studies obtained utility directly from patients, while the others inquired ophthalmologists or community members to estimate utility. Standard Gamble (SG) and time-trade off (TTO) were the most commonly techniques used in these studies (11 studies used TTO, while 5 studies used SG). Based on a meta-analysis of three studies which obtained utility from 510 patients and provided suffi cient data for calculation, the utility values with 95% confi dence intervals for visual acuity of 20/20-20/25, 20/30-20/50, 20/60-20/100, 20/200-20/400 and <20/400 were 0.91 (0.88-0.94), 0.81 (0.78-0.84), 0.68 (0.58-0.77), 0.62 (0.55-0.68), and 0.46 (0.33-0.59) respectively. CONCLUSIONS: Our fi ndings provided the pooled estimates of utilities for AMD patients for all visual acuity levels. It was found that the better visual acuity, the higher utility value. Researchers may use our pooled utilities as input parameters in their cost-effectiveness modeling studies. OBJECTIVES: Psoriasis has a major impact on patients' quality of life, as commonly measured by the Dermatology Life Quality Index (DLQI). This study has two objectives: 1) to measure health-related utilities for patients with psoriasis and to measure the willingness-to-pay (WTP) for a cure for psoriasis, and 2) to examine how these different measures of utilities and WTP were related to DLQI. METHODS: Face-toface patient interviews were carried out with 364 patients with psoriasis during August 2009 and February 2010 at dermatology outpatient clinics in fi ve hospitals located in northern, central and southern Taiwan. Utilities were elicited using time trade-off (TTO), visual analogue scale (VAS) and EQ-5D. The EQ-5D was scored based on the standard scoring formula. The WTP for a cure of psoriasis was elicited by double bounded binary-choice questions followed by a bidding game question. RESULTS: Mean age was 44.5 years, mean history of disease was 11.2 years, and 77% of patients were male. The mean health utility was 0.87 (EQ-5D), 0.72 (VAS) and 0.75 (TTO). The WTP per month was between NT$7770.72 and NT$9411.50. Scores of EQ-5D and VAS were signifi cantly negatively correlated to all of the dimensions of DLQI. The correlation of the dichotomous WTP with DLQI was also strong and in the expected direction. TTO was also signifi cantly correlated with DLQI, but the relation was the weakest. CONCLUSIONS: EQ-5D, VAS and WTP are consistent measures with DLQI in assessing the well-being of patients with psoriasis in Taiwan.
PSS11 MEDICATION CHOICE AND ASSOCIATED HEALTH-CARE OUTCOMES AND COSTS FOR PATIENTS WITH PSORIASIS IN THE UNITED STATES
Lin HC 1 , Balkrishnan R 1 , Lucas PTR 2 , Feldman SR 3 1 University of Michigan, Ann Arbor, MI, USA; 2 Universidade de Lisboa, Lisboa, Portugal; 3 Wake Forest University, Winston-Salem, NC, USA OBJECTIVES: The impact of choice of pharmacotherapy for psoriasis on costs and patient outcomes in large nationally representative data in the United States needs further examination. This study examined the impacts of patient demographics and medication choices on patient's health status and associated medication costs in the United States. METHODS: A retrospective cross-sectional study was conducted using the 2007 Medical Expenditure Panel Survey (MEPS) database. Information on patient demographics, health status, medication utilization, and medication costs were obtained from the database representing 605,089 patients with psoriasis. Weighted multiple linear regressions were used to examine the impacts of patient demographics and medication choices on patient's health status and associated medication costs. RESULTS: Weighted multiple linear regression analyses indicated that the use of topical corticosteroids yielded 23.0% lower annual medication costs (compared to nonusers in logarithm format; P = 0.00), whereas the use of biological/systemic agents yielded 41.8% higher annual medication costs (compared to nonusers in logarithm format; P = 0.00). The study population using topical corticosteroids had 35.0% improvement in SF-12 PCS scores (compared to nonusers; P = 0.00), whereas patients using biological/systemic agents had 8.2% improvement in SF-12 PCS scores (compared to nonusers; P = 0.00. ) The use of biological agents was elevated compared to previous studies. CONCLUSIONS: We observed an association with medication choice for psoriasis treatment on associated patient health status and medication spending in the United States. The retrospective nature of the study precludes assessment of causality, but encouraging use of topical treatments may be an effective means to reduce psoriasis management costs.
PSS12 PSYCHOMETRIC EVALUATION OF MYOPIA-SPECIFIC INSTRUMENTS USED TO ASSESS HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS RECEIVING LASIK SURGERY
Huang MY University of Georgia, Athens, GA, USA OBJECTIVES: The objective of this study is to identify an existing instrument which could measure the health related quality of life of myopia patients receiving refractive surgery such as LASIK for group-level and individual-level decision-making. METHODS: Seven instruments were identifi ed through a comprehensive literature search. Based on the criteria defi ned by Scientifi c Advisory committee of the Medical Outcome Trust (2002), selected instruments were evaluated using 12 criteria related to conceptual model, reliability (internal consistency and test-retest), validity(content validity and construct validity), responsiveness(cross-sectional and longitudinal), interpretability(availability of norms and quality of norms), burden(respondent and administrator), and depth. RESULTS: For the seven identifi ed instruments, two were excluded because language criteria and one was excluded because it measured satisfaction, not HRQOL. The remaining four instruments included National Eye Institute Refractive Error Quality of Life (NEI-RQL), Refractive Status and Vision Profi le (RSVP), Quality of Life Impact of Refractive Correction (QIRC), Quality-of-life Scale for Myopia (QOLM). For 12 individual decision-making criteria, NEI-RQL, RSVP, QIRC and QOLM met 7, 7, 6, 5 criteria, respectively. For 12 group-level decisionmaking criteria, NEI-RQL, RSVP, QIRC and QOLM met 9, 7, 8, 7 criteria, respectively. CONCLUSIONS: Existing instruments do not fully meet the evaluation criteria. Most instruments lacked information or had problems with reliability (individual-level decision-making), longitudinal responsiveness, administrator burden, and depth. This study results showed that NEI-RQL met the most of the criteria. For an international study, the NEI-RQL-42 had to be translated and linguistically validated in Simplifi ed Chinese for China and Hindi for India. METHODS: A standardized linguistic validation methodology was conducted by specialists for each target country: 1) concept defi nition; 2) dual forward translations by independent native-speaking linguists; 3) reconcili-ation of the forward translations; 4) back translation into English by a native speaking linguist; 5) resolution of the back translation; 6) international harmonization; 7) clinician (Ophthalmologist) review; 8) cognitive debriefi ng comprehension interviews on fi ve Mandarin/Simplifi ed Chinese and fi ve Hindi native-speaking patients who are either pre-or post-cataract surgery; and 9) fi nal proofreading. RESULTS: The main challenge on the conceptual level was the English original made extensive use of driving scenarios during the day and night in the US English source instrument to elicit responses. For Hindi and Simplifi ed Chinese, driving scenarios were supplemented with walking and cycling, which were more relevant in the local context without compromising the conceptual intent of the source instrument. On the linguistic level, translating some of the frequency terms required discussion with the developer to identify a solution, as the gradation between the surrounding English response options was diffi cult to exactly match on a conceptual level in the target language due to linguistic limitations. CONCLUSIONS: According to the rigorous methodology used, with some minor adjustments, the Mandarin and Hindi versions of the NEI-RQl-42 were qualitatively conceptually equivalent and culturally relevant. The Simplifi ed Chinese and Hindi versions were successfully linguistically validated to measurement of the impact of refractive error on patients' day-to-day lives and facilitate the comparison and pooling of data.
PSS13 LINGUISTIC VALIDATION OF THE NATIONAL EYE INSTITUTE-QUALITY OF LIFE QUESTIONNAIRE-42 (NEI-RQL-42) FOR PATIENTS WITH REFRACTIVE ERROR MODIFIED FOR SIMPLIFIED CHINESE IN MAINLAND CHINA AND HINDI IN INDIA
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PSS14 WHAT COST OF HLA-B*5801 GENOTYPING WOULD BE COST-EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND: ANALYSES USING A DECISION-ANALYTIC MODEL
Somkrua R 1 , Chaiyakunapruk N 2 , Tassaneeyakul W 3 1 Center of Pharmaceutical Outcome Research, Naresuan University, Muang, Phitsanulok, Thailand; 2 Naresuan University, Muang, Phitsanulok, Thailand, 3 Department of Pharmacology, Faculty of Medicine, Khon Kaen, Thailand OBJECTIVES: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), caused by allopurinol therapy, are strongly associated with the human leukocyte antigen (HLA), HLA-B*5801. It was unclear at what price the genetic testing would be a cost-effective strategy compared to no testing. This study aims to determine the range of genotyping cost that would be cost-effective from health-care provider perspective. METHODS: A decision analytic model was used to estimate the cost-
